上海医药
上海醫藥
상해의약
SHANGHAI MEDICAL & PHARMACEUTICAL JOURNAL
2013年
17期
34-36,37
,共4页
强胜%黄敏%冯春俭%杜珍芳
彊勝%黃敏%馮春儉%杜珍芳
강성%황민%풍춘검%두진방
温肾降浊通络法%慢性肾功能衰竭%中医药疗法
溫腎降濁通絡法%慢性腎功能衰竭%中醫藥療法
온신강탁통락법%만성신공능쇠갈%중의약요법
the method of Wenshen-Jiangzhuo-Tongluo%chronic renal failure%traditional Chinese medicine
目的:观察温肾降浊通络法治疗早中期慢性肾功能衰竭(CRF)的临床疗效。方法:选择早中期CRF患者112例作为研究对象,随机分为治疗组和对照组。治疗组60例在常规治疗基础上加用温肾降浊通络汤加减,对照组52例在常规治疗基础上加服包醛氧淀粉,2组均以1个月为一疗程,服用两个疗程后观察两组患者临床疗效。结果:治疗组总有效率80.00%,对照组总有效率57.69%,两组疾病疗效比较差别有统计学意义(P<0.05);在24 h尿蛋白定量(24 UTP)、血红蛋白(HB)、总胆固醇(TC)、血肌酐(Scr)方面,治疗组疗效优于对照组(P<0.05)。结论:温肾降浊通络法不仅能改善慢性肾功能衰竭患者的临床症状,而且能改善肾功能、血脂、血红蛋白。
目的:觀察溫腎降濁通絡法治療早中期慢性腎功能衰竭(CRF)的臨床療效。方法:選擇早中期CRF患者112例作為研究對象,隨機分為治療組和對照組。治療組60例在常規治療基礎上加用溫腎降濁通絡湯加減,對照組52例在常規治療基礎上加服包醛氧澱粉,2組均以1箇月為一療程,服用兩箇療程後觀察兩組患者臨床療效。結果:治療組總有效率80.00%,對照組總有效率57.69%,兩組疾病療效比較差彆有統計學意義(P<0.05);在24 h尿蛋白定量(24 UTP)、血紅蛋白(HB)、總膽固醇(TC)、血肌酐(Scr)方麵,治療組療效優于對照組(P<0.05)。結論:溫腎降濁通絡法不僅能改善慢性腎功能衰竭患者的臨床癥狀,而且能改善腎功能、血脂、血紅蛋白。
목적:관찰온신강탁통락법치료조중기만성신공능쇠갈(CRF)적림상료효。방법:선택조중기CRF환자112례작위연구대상,수궤분위치료조화대조조。치료조60례재상규치료기출상가용온신강탁통락탕가감,대조조52례재상규치료기출상가복포철양정분,2조균이1개월위일료정,복용량개료정후관찰량조환자림상료효。결과:치료조총유효솔80.00%,대조조총유효솔57.69%,량조질병료효비교차별유통계학의의(P<0.05);재24 h뇨단백정량(24 UTP)、혈홍단백(HB)、총담고순(TC)、혈기항(Scr)방면,치료조료효우우대조조(P<0.05)。결론:온신강탁통락법불부능개선만성신공능쇠갈환자적림상증상,이차능개선신공능、혈지、혈홍단백。
Objective:To observe the clinical efifcacy of Wenshen-Jiangzhuo-Tongluo in the treatment of patients with early and middle chronic renal failure (CRF). Methods:Patients with early and middle CRF treated in our hospital from January 2009 to January 2013 were randomly divided into a treatment group (60 cases, treated with conventional therapy combined with Wenshen-Jiangzhuo-Tongluo) and a control group (52 cases, treated with conventional therapy combined with package aldehyde oxygen starch). Two groups were treated for one month as a course. Clinical efifcacy was analyzed after two courses of treatment. Results:The total effective rate in the treatment group accounted for 80.00% compared with 57.69% in the control group. There were some signiifcant differences in 24 UTP、HB、TC、Scr between two groups before and after treatment, which were statistically signiifcant (P<0.05). Conclusion:The treatment of Wenshen-Jiangzhuo-Tongluo can improve not only the clinical symptoms in the patients of chronic renal failure, but also the function of renal and the levels of blood lipids and hemoglobin.